Exosomes are membrane vesicles of endocytic origin that can mediate communication between cells and the transport of cellular components such as microRNAs, mRNAs, proteins and DNA. Recently, exosomes have been under investigation for their significant roles in both healthy physiology and disease states. Herein, we review the role of exosomes in chronic inflammatory skin diseases and skin tumors, especially focusing on systemic lupus erythematosus, psoriasis, atopic dermatitis, bullous pemphigoid and melanoma. Moreover, we emphasize the involvement of changes in exosome cargo in the regulation of these diseases.
| INTRODUC TI ON
Exosomes are extracellular vesicles that can be described as saucershaped vesicles of 30-100 nm in diameter. [1] Exosomes, which contain lipids, proteins and nucleic acids, mediate membrane transport and communication between cells. [2, 3] In both healthy and unhealthy individuals, exosomes are released by many cells and can be found in a wide range of bodily fluids, such as blood, urine, breast milk and saliva, and in the supernatants of cultured cells. [4] Exosomes are composed of a lipid bilayer, proteins and nucleic acids. Many proteins have been found in exosomes, depending on the cells that release them, including vesicle formation proteins (Alix, Tsg101), membrane fusion-related proteins such as Rab GTPases, flotillins and connexins, and integral membrane proteins such as tetraspanins (CD9, CD63, CD81). [4] Depending on different physiological or pathophysiological conditions, the cell type and the tissue of origin, exosome secretion can be spontaneous or induced, and exosomes can include different molecular make-ups and cargo. [5] Exosomes are involved in many physiological processes, both beneficial and pathological. Studies have shown that they play important roles in gene expression and cellular signalling, and are also involved in the progression of diseases, including tumor growth and autoimmune diseases. [6, 7] Exosomes, which are secreted by non-immune and immune cells (including T cells, B cells, dendritic cells and macrophages), can both stimulate and inhibit the immune system. Effects of exosomes on immunity include T-cell activation, T-cell polarization into regulatory T cells, immune suppression, anti-inflammation and others. [8] Exosomes secreted by tumor cells support tumor progression and metastasis by promoting tumor initiation, angiogenesis, epithelial-to-mesenchymal transition (EMT), matrix remodelling and immune modulation. [9] The skin is the largest multifunctional organ in the body and provides a barrier between the body and the environment to protect against assault by foreign organisms or toxic substances. As an interface, the skin is also colonized by a variety of microorganisms, including bacteria, fungi and viruses. [10] The skin is composed of three layers: first, the epidermis, which mainly consists of keratinocytes and dendritic cells; second, the dermis, which is rich in blood vessels, nerve endings and connective tissue; third, the subcutaneous tissue, which mainly consists of fat cells divided by fibrous septa. [11, 12] Dysfunction of the skin can lead to a range of diseases. Skin disease patients not only face decreased quality of life, but also are often embarrassed about the appearance of their skin, which can cause an immense psychological burden. Increasing evidence has shown that exosomes are involved in the pathogenesis of skin diseases. In this review, we examine recent evidence associating exosomes with a role in chronic inflammatory skin diseases and skin tumors. We review the potential mechanisms by which exosomes participate in the pathogenesis of these dermatoses. Moreover, we also discuss the therapeutic potential of targeting exosomes for chronic inflammatory skin diseases and skin tumors.
| Exosomes isolation techniques
The isolation of exosomes from a wide spectrum of cellular debris and interfering components is crucial for the study of exosomes.
There are several exosome isolation techniques have been developed. Ultracentrifugation-based isolation techniques are commonly used and isolate exosomes according to their density, size and shape.
The exosomes isolated by this method have low purity, so ultracentrifugation is often coupled to isopycnic or moving-zone techniques to further purify the exosomes. [13] Size-based isolation techniques isolate exosomes dependent on their size or molecular weight, but are restricted by exosome saturation limits and low recovery rates. [14] Immunoaffinity capture-based techniques rely on specific biomarkers present on exosome outer surfaces and are a platform for selectively isolating exosomes of a specific origin. The exosomes obtained by this method are supposed to be high purity. [15] Exosome precipitation is based on altering solubility or dispersibility of exosomes. [13] For easy to use and does not require specialized equipment, it is scalable for large sample sizes. [16] Microfluidics-based isolation techniques are based on a variety of physical and biochemical characters of exosomes, such as size, density and immunoaffinity. Several kinds of mechanisms are needed like acoustic, electrophoretic and electromagnetic. [13, 17, 18] For the downstream study, Western blot, fluorescence-activated cell sorting (FACS), ELISA, [19] trypsin digestion and mass spectrometry [20, 21] can be used for the analysis of exosomal proteins. [1] Gene expression microarrays, qPCR and RNA sequencing can be used for the analysis of exosomal RNAs. [22] The progress of exosome isolation techniques has improved the efficiency of exosome isolation. However, the advantages and disadvantages of each technique needed to be taken into consideration when make choices.
| IMP ORTAN CE OF E XOSOME S IN CHRONI C INFL AMMATORY S K IN D IS E A S E S

| Exosomes and systemic lupus erythematosus (SLE)
SLE is a chronic, multisystemic, autoimmune disease that can affect virtually every organ. The clinical main few stations of SLE range from mild mucocutaneous symptoms to life-threatening illness. The pathogenesis of SLE is not fully elucidated, but it may be caused by interactions among immunologic, genetic and environmental risk factors, such as ultraviolet light, infections and viruses, resulting in an irreversible loss of immunologic self-tolerance. [23] As exosomes are rich in acetylcholinesterase (AChE), this enzyme can be used to estimate the level of exosomes in serum. Based on an AChE assay, the serum levels of exosomes in SLE patients were found to be significantly upregulated compared with healthy controls. The level of exosomes was correlated with disease activity in the SLE patients. [24] In addition, exosomes purified from SLE patients induce higher cytokine production by peripheral blood mononuclear cells (PBMC) from healthy controls, including the production of in-
and IL-6. [24] Elevated levels of IFN-α have been considered a pathogenic mechanism of SLE. Previous studies showed that exosomes from SLE patients can induce the release of IFN-α by human plasmacytoid dendritic cells and that the active components may be microRNAs (miRNAs). [25] Exosomes can be found in a variety of bodily fluids, such as plasma, urine and saliva. [26] Because of the easy access and noninvasive collection of urine, exosomes in urine are an approach to studying renal diseases. Emerging evidence suggests that miRNAs play an important role in the development of many diseases. [27] Perez-Hernandez and colleagues have demonstrated that, in SLE patients, urinary miRNAs are contained primarily in exosomes and are significantly increased compared with controls, especially for miR-146a. Additionally, in a patient group with active lupus nephritis (LN), the levels of exosomal miRNAs were more strongly upregulated compared with inactive LN, SLE in the absence of LN and controls. [28] As miRNAs in exosomes are protected from degradation by endogenous RNases, these miRNAs are more stable than circulating RNAs. [7] Thus, miRNAs derived from exosomes are potential biomarkers for the diagnosis and prognosis of SLE.
Taken together, these observations indicate that exosomes possibly contribute to the development of SLE, and components of the exosome cargo may act as diagnostic and prognostic biomarkers.
Moreover, removal of the exosomes might be a novel therapeutic approach for SLE.
| Exosomes and bullous pemphigoid (BP)
Bullous pemphigoid is an autoimmune blistering disease characterized by autoantibodies against the hemidesmosomal proteins, BP180
and BP230, which are deposited in the epithelial basement membrane zone. [29] The histological presentation of BP may vary with clinical presentation, but typical histopathological findings are subepidermal blisters with inflammatory cell infiltrates of variable intensity, composed of lymphocytes, neutrophils, and characteristically, eosinophils. [30] Fang and colleagues have found that CD63, CD81
and CD9 are marker proteins in exosomes purified from the blister fluids of BP patients. Exosomes isolated from blister fluids can be internalized by human primary keratinocytes. In addition, the production by keratinocytes of TNF-α, CXCL8 and IL-6 can be induced by blister fluid-derived exosomes, which may act through the extracellular signal-regulated kinase 1/2 and signal transducer and activator of transcription 3 signalling pathways. [31] However, the relationship between blister fluid-derived exosomes and autoantigen-related proteins, such as BP180 and BP230, has not been determined. In conclusion, blister fluid-derived exosomes may be involved in the pathogenesis of BP, but the mechanism by which they contribute to BP is unclear.
| Exosomes and psoriasis
Psoriasis is a chronic, autoimmune, inflammatory skin disorder affecting patients internally, externally and psychosocially in various ways. [32, 33] It is characterized by raised, well-demarcated erythematic papules with adherent shiny scales. [10] Psoriatic arthritis (PsA)
is associated with progressive joint damage, and patients have a substantial burden of physical impairment. [34] Exosomes derived from
PsA blood samples can enhance osteoclastogenesis. Age, disease duration, disease activity, C-reactive protein levels and erythrocyte sedimentation rates have been found to show no association with this osteoclastogenesis stimulatory effect. [35] These findings suggest that exosomes may be effective and context-dependent regulators of human osteoclastogenesis.
Langerhans cells (LCs) in psoriasis patients show impaired migration and play a role in disease pathogenesis. CD1a is constitutively expressed by LCs of the epidermis. [36] Previous studies have revealed that mast cells are enriched in psoriatic lesions. 37 Multiple lines of evidence support the notion that T cells play a crucial role in the pathogenesis of psoriasis. Phospholipase A 2 (PLA 2 ) activity has been proved to be related to lipid-specific T-cell inflammatory skin responses. In psoriasis patients, the elevation of systemic PLA 2 activity has been proposed to be associated with metabolic syndrome. [38] Cheung and colleagues have discovered that IFN-α enhances the release of exosomes by mast cells. Additionally, circulating CD1a-autoreactive T cells are enriched in psoriasis patients and respond to PLA 2 -containing exosomes from the LAD2 mast celllike line, and PLA 2 can lead to the increased production of IL-22 and IL-17A by CD1a-autoreactive T cells. [39] These findings also suggest that non-peptide antigens, such as neolipids, may be vital activators of T cells, and exosomes may be important carriers for these antigens. Although these findings indicate that the inhibition of PLA 2 or CD1a may be a potential new therapy for psoriasis, substantial studies are needed to confirm this.
| Exosomes and atopic dermatitis (AD)
AD is a chronic, recurrent skin disease with substantial effects on quality of life. The pathophysiology of AD includes dysfunction of the skin barrier and dysregulation of skin inflammation and immunity, and potentially involves multiple genes.
[ 40] Adipose tissue (AT)-derived exosomes inhibit lipopolysaccharideinduced nitric oxide production in RAW264. Following systemic administration, AT exosomes relieved AD-like symptoms, and downregulation of IL-4, IL-31, IL-23 and TNF-α mRNA levels was also observed in the skin lesions. [41] This study suggests a role for AT exosomes in immune modulation, and AT exosomes may offer a cell-free therapy for AD, but more studies are needed to confirm their potential.
Recent studies have demonstrated that dysbiosis of the skin microbiota and colonization by Staphylococcus aureus are common in AD. [42] However, the exact mechanism of skin microbiota involvement in AD patients is not clear. Hong and colleagues have revealed that the serum levels of extracellular vesicles incorporating
Staphylococcus aureus-specific IgE are significantly increased in AD patients compared with healthy controls. In dermal fibroblasts, the production of IL-6, thymic stromal lymphopoietin, macrophage inflammatory protein-1α and eotaxin can be increased by extracellular vesicles derived from Staphylococcus aureus. These extracellular vesicles also cause epidermal thickening and upregulate the expression of IL-4, IL-5, IFN-γ and IL-17.
[ 43] pH plays an important role in the skin barrier. The cutaneous pH values of AD patients are higher compared with normal humans. [44] Malassezia sympodialis is associated with AD and can secrete nanosized exosome-like vesicles which carry allergens. [45, 46] These vesicles up-regulate IL-4 production in CD14/CD34-depleted PBMC from AD patients. In CD14/CD34-depleted PBMC from both AD patients and healthy controls, exosomes from monocyte-derived dendritic cells and Malassezia sympodialis co-cultures induce IL-4 and TNF-α responses. [46] Further studies have found that the total num-
ber, size and protein concentration of exosome-like vesicles from
Malassezia sympodialis show no differences between pH 5.5 and pH 6.1. However, a 16-22 nucleotide RNA sequence was identified as consistently present in exosome-like vesicles from Malassezia sympodialis, the function of which remains to be clarified. [47] These findings contribute to our understanding of host-microbe interactions in the pathogenesis of AD. However, this research is just the tip of an iceberg, and further studies will be needed to confirm and explain the mechanisms underlying the involvement of exosomes and fungiderived exosome-like vesicles in the pathogenesis of AD.
| Exosomes and systemic sclerosis
The scleroderma disorders include a heterogeneous group of conditions involving the skin, musculoskeletal system and several internal organs. [48] The scleroderma disorders are mainly divided into two forms: localized scleroderma and systemic sclerosis. [49] Nakamura and colleagues demonstrated that the mRNA levels of exosome markers (CD63, CD9 and CD81) were increased in the skin of systemic sclerosis patients compared to those in normal subjects. On the contrary, the levels of exosomes were decreased in the sera of systemic sclerosis patients compared to normal sera. Vascular abnormalities, which can disrupt the transfer of exosomes derived from fibrocytes to the bloodstream, may account for the decreased serum exosome levels. [50] Wermuth and colleagues have found that the levels of nine profibrotic miRNAs (miR-let-7 g-5p, miR-17-5p, miR-21-5p, miR-23b-5p, miR-29a-3p, miR-150-5p, miR-155-5p, miR-215-5p and miR-503-5p)
were increased and fourteen antifibrotic miRNAs (miR-26b-5p, miR-129-5p, miR-145-5p, miR-196a-5p, miR-200b-3p, miR-223-3p, miR-let-7a-5p, miR-29b-3p, miR-92a-3p, miR-125b-5p, miR-133a-3p, miR-140-5p, miR-146a-5p and miR-200a-3p) were decreased in exosomes isolated from the serum of systemic sclerosis patients compared to normal serum exosomes. Exosomes isolated from both limited and diffuse systemic sclerosis patients can upregulate the expression of profibrotic genes and the production and secretion of type I collagen and fibronectin of cultured normal human dermal fibroblasts in a dose-dependent manner. This study suggested that the serum exosomes may play profibrotic role in systemic sclerosis patients. [51] Exosomes may exist as an autoantigenic complex.
Previous studies have demonstrated that hRrp4p, hRrp40p, hRrp41p, hRrp42p, hRrp46p and hCsl4p are six novel human exosome components. [52, 53] Autoantibodies directed to the human exosome components (hRrp4p, hRrp40p, hRrp41p, hRrp42p, hRrp46p and hCsl4p) were detected in sera from scleroderma patients and the polymyositis/scleroderma overlap syndrome. [54, 55] In summary, these findings suggest that exosomes may play an important role in the development of systemic sclerosis. Further indepth studies are required to determine whether exosomes can be utilized as a novel pathway for regulating systemic sclerosis in the future.
| IMP ORTAN CE OF E XOSOME S IN S KIN TUMOR S
| Exosomes and melanoma
Cutaneous melanoma is a very aggressive type of cancer with an increasing incidence. The pathogenesis of melanoma involves genetic, epigenetic and environmental factors, such as skin type, sun exposure, multiple nevi, age, immune status and family or personal history of melanoma. [56, 57] Increasing evidence shows that exosomes are related to the pathogenesis of melanoma. By separating melanomaderived exosomes from non-tumor cell-derived exosomes, Sharma and colleagues found that melanoma-related antigens in melanoma patients are the cargo of melanoma-derived exosomes, not normal cell-derived exosomes. [58] Melanoma-derived exosomes promote the growth and metastasis of melanoma. Macrophages, which can be divided into M1 (anti-tumor) and M2 (protumor) activation phenotypes, play a crucial role in melanoma growth and survival. IL-1β, IL-6, i-NOS, TLR-9 and TNF-α) was observed. The upregulation of TGF-β was only detected in primary macrophages. Overall, melanoma-derived exosomes induce a protumor macrophage activation phenotype. [59] EMT is vital for the distant metastasis of cancers. [60, 61] The invasion and migration of primary melanocytes can be enhanced through an EMT-resembling process induced by exosomes derived from melanoma cells. [62] CD8+ T lymphocytes play a crucial role in adaptive immunity and can directly kill cancer cells. [63] As a non-receptor phosphotyrosine phosphatase, PTPN11 inhibits the interferon, IL-2 and T-cell receptor signalling pathways, which are related to anti-tumor immunity. [64, 65] Exosomes derived from the B16F0 melanoma cell line inhibit CD8+ Tlymphocyte proliferation through their increased expression of both PTPN11 protein and mRNA. [66] Previous studies have discovered that natural killer (NK) cells may be associated with the immune response against tumors. [67, 68] NK-92 cell line-derived exosomes exert cytotoxic effects against melanoma, which are partly associated with the functional protein, FasL. [69] These findings suggest that interaction between melanoma and other immune cells can also influence the pathogenesis of melanoma, both beneficially and pathologically.
miRNAs are small, non-coding RNAs that are important gene expression regulators. Research has revealed that the dysregulation of miRNAs may be associated with melanoma progression. [70] The expression levels of miR-532-5p and miR-106b were significantly higher in exosomes collected from the serum of the melanoma patients compared with healthy controls. This study also suggested that miR-532-5p and miR-106b in exosomes can be used to distinguish melanoma patients from healthy individuals, patients with metastasis from non-metastatic patients and stage I-II patients from stage III-IV patients. [71] Another study found miR-17, miR-19a, miR-21, miR-126 and miR-149 in exosomes derived from the plasma of metastatic melanoma patients. [72] However, the expression of miR125b was significantly lower in exosomes from melanoma patients than those from healthy controls. [73] Overall, whether the differential expression of miRNAs in exosomes from different melanoma patient cohorts can be used as biomarkers for melanoma metastasis requires further examination. response to PD-L1 inhibitor treatment. [74] In melanoma patients receiving PD-1 inhibitor treatment, higher basal levels of PD-1 and CD28 in exosomes derived from T cells were associated with prolonged progression-free survival and improved overall survival. [75] These findings indicate that exosomes are potential predictors of the response to PD-L1 inhibitors and PD-1 inhibitors. The differential expression of exosome cargos may also be related to patients' responses to therapeutic intervention.
Taken together, these data indicate that exosomes play a crucial role in melanoma development and metastasis, and may be useful predictive biomarkers for diagnosis and therapeutic response.
However, the data are mostly limited to studies in animal models and in cells in vitro.
| Exosomes and squamous cell carcinoma (SCC)
SCC presents with a wide variety of clinical manifestations and can develop in sites, including the skin, oral cavity, oesophagus and lung.
It is demonstrated that radiation can upregulate exosome release in head and neck SCC cell line and increase the uptake of exosome by recipient cells. In addition, exosomes from both irradiated and non-irradiated head and neck SCC cells can transmit prosurvival effect on recipient cells. [76] Ionizing radiation can affect the protein composition in exosomes isolated from head and neck SCC cells, and the upregulated proteins play roles in translation, transcription cell division and cell signing. [77] Exosomes derived from stromal fibroblasts of oral SCC patients, which contains TGFβ type II receptor, can re-activate the TGFβ signalling in SCC keratinocytes. [78] Despite the current knowledge suggests the involvement of exosomes may in the pathogenesis, the exact role and mechanism of exosomes in SCC remain unclear.
| CON CLUS ION
In conclusion, this article reviews recent findings about the possible role of exosomes in SLE, psoriasis, AD, BP and melanoma. However, the molecular mechanisms behind exosome involvement in chronic inflammatory skin diseases and skin tumors remain elusive. The co-stimulatory molecules, miRNAs and proteins in exosomes from different cells and their roles in the above diseases remain to be determined. Overall, studies to date have been somewhat superficial, and further research is required to clarify the roles of exosomes in the processes of chronic inflammatory skin diseases and skin tumors.
More importantly, evidence on the safety and efficacy of exosomebased clinical therapies in humans is lacking. Further investigations are also needed to evaluate the potential of exosomes as diagnostic markers and predictors of prognosis and therapeutic reactions.
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